MINI REVIEW
Accepted on 11 Dec 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Epitranscriptomic Regulation of Anti-Tumor Immunity
Epitranscriptomic Regulation of Anti-Tumor Immunity
168
Total downloads
5,682
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 02 Dec 2025
Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation
doi 10.3389/fimmu.2025.1711451
- 770 views
MINI REVIEW
Published on 19 Nov 2025
Unveiling the immunological functions of the RNA m5C reader YBX1 in cancer
doi 10.3389/fimmu.2025.1703697
- 612 views
REVIEW
Published on 07 Nov 2025
Epitranscriptomic control of cancer immunity and therapy resistance
doi 10.3389/fimmu.2025.1706557
- 1,908 views
MINI REVIEW
Published on 03 Nov 2025
Roles and mechanisms of NSUN2-mediated RNA m5C modification in cancer progression and immune modulation
doi 10.3389/fimmu.2025.1702436
- 1,199 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: